{"data":[{"accessionNo":"0001649553-26-000030","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"CVI Investments, Inc.","reportingCik":null,"personType":"CO","sharesOwned":1194719,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001649553-26-000030","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Heights Capital Management, Inc.","reportingCik":null,"personType":"CO","sharesOwned":1194719,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001213900-26-016522","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Mitchell P. Kopin","reportingCik":null,"personType":"HC,IN","sharesOwned":1142556,"percentOfClass":9.1,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001213900-26-016522","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Daniel B. Asher","reportingCik":null,"personType":"HC,IN","sharesOwned":1142556,"percentOfClass":9.1,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001213900-26-016522","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Intracoastal Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":1142556,"percentOfClass":9.1,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001493152-25-027252","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-08","reportingPerson":"Orca Capital AG","reportingCik":null,"personType":"CO","sharesOwned":538707,"percentOfClass":4.9,"filedAt":"2025-12-11","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001493152-25-024820","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-20","reportingPerson":"Orca Capital AG","reportingCik":null,"personType":"CO","sharesOwned":700421,"percentOfClass":6.5,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001493152-25-021629","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-07","reportingPerson":"Orca Capital AG","reportingCik":null,"personType":"CO","sharesOwned":409261,"percentOfClass":4.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001649553-25-000206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-03","reportingPerson":"CVI Investments, Inc.","reportingCik":null,"personType":"CO","sharesOwned":733344,"percentOfClass":9.9,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001649553-25-000206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-03","reportingPerson":"Heights Capital Management, Inc.","reportingCik":null,"personType":"CO","sharesOwned":733344,"percentOfClass":9.9,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001213900-25-107723","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Mitchell P. Kopin","reportingCik":null,"personType":"HC,IN","sharesOwned":430000,"percentOfClass":7,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001213900-25-107723","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Daniel B. Asher","reportingCik":null,"personType":"HC,IN","sharesOwned":430000,"percentOfClass":7,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001213900-25-107723","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Intracoastal Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":430000,"percentOfClass":7,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/phio"},{"accessionNo":"0001493152-25-021091","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001533040","issuerName":"Phio Pharmaceuticals Corp.","ticker":"PHIO","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-03","reportingPerson":"Orca Capital AG","reportingCik":null,"personType":"CO","sharesOwned":800000,"percentOfClass":9.8,"filedAt":"2025-11-06","canonicalUrl":"https://xoomar.com/markets/stocks/phio"}],"updatedAt":"2026-11-04T07:04:44.666Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/phio","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}